Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02822508 · ClinicalTrials.gov registry record · Phase 2
A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation
A Phase 2 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 434
- Enrollment target
NCT02822508 is a Phase 2 study that has completed, run by Braintree Laboratories. The registered enrollment target is 434 participants.
The verdict
NCT02822508, a Phase 2 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 434 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate multiple doses of BLI801 Laxative for safety and efficacy versus placebo in adults experiencing non-idiopathic constipation.
Interventions
- DRUG BLI801 Laxative
- DRUG BLI801 Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 434 participants |
| Start Date | 2016-06 |
| Est. Completion | 2017-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02822508
The ClinicalTrials.gov registry entry for NCT02822508 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 434 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BLI801 Laxative is the first listed.
NCT02822508 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02822508 about?
NCT02822508 is a clinical study titled "A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation". The objective of this study is to evaluate multiple doses of BLI801 Laxative for safety and efficacy versus placebo in adults experiencing non-idiopathic constipation.
What is the current status of trial NCT02822508?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 434 participants. The study started on 2016-06. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02822508?
The interventions under investigation include: BLI801 Laxative (DRUG), BLI801 Placebo (DRUG).
Who is sponsoring clinical trial NCT02822508?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.